By Candice He, Global Investment Strategist, LSN

As a co-organizer of RESI Shanghai, Enmore has become a valuable partner of Life Science Nation, utilizing their expertise in the local market and as conference organizers to make RESI a success, with more than 450 investors, startups and service providers in attendance. LSN and Enmore have a common goal of creating an international ecosystem for advancing life science technologies to market in a global economy, and will continue to partner to achieve this. For those interested in exploring the China market and establishing relationships with key players in the China life science ecosystem, we invite you to attend the Enmore Bio Conference, taking place at the Suzhou International Expo Center from February 20-22, 2020.
What is EBC?
Enmore Bio Conference (EBC) is the largest and most influential bio-industry conference in China, as well as the most open conference platform jointly created by Enmore Healthcare, the organizer, and many industry associations, institutions, companies and experts for the whole industry chain.
EBC consists of four parallel conferences: the 10th Antibody Drugs & Novel Biological Summit, the 8th Molecular Diagnostics Summit, the 6th Immunotherapy Industry Summit, and the 3rd 17TALK Healthcare Investment & Financing Leadership Forum. The four-in-one event covers topics concerning the whole industry chain of diagnosis, treatment and medication, and other topics like CDx, target development, clinical research and policy discussion will also be touched through a dozen of special forums. The Enmore Bio Exhibition, as part of this event, will attract more than 200 suppliers of instruments, consumables and services. The EBC, which combines conference and exhibition, has become a benchmark platform for high-level exchanges and cooperation in the bio-industry in China and abroad.
Conference website: http://ebc.enmorebiz.com/english.html

Why choose EBC?
EBC is committed to building China’s largest and most influential bio industry event through four parallel conferences, a dozen of co-organized forums, three invited-only meetings for CEOs and pre-event business visits. More than 150 enterprise leaders and experts will make presentations during this event.
Previous reports of EBC:
https://mp.weixin.qq.com/s/h1YQvgaOpClaYRUmNFAmdg
http://ebc2019.enmorebiz.com
Co-organizations of EBC 2020
Guangzhou KingMed Diagnostics Group Co., Ltd.
PersonGene
Wuhan Tongji Hospital
Renmin Hospital Of Wuhan University
Shanghai Junshi Biosciences Co., Ltd.
Hengrui Medcine
Innoforce Pharmaceuticals Co., Ltd.
TOT Biopharm
SAPA-China
Everbright Medical & Healthcare Fund
EBC parallel conferences:
10th Antibody Drugs & Novel Biological Summit
The 10th Antibody Drugs & Novel Biological Summit is co-organized by Junshi Biosciences, Hengrui Medicine, Innoforce Pharmaceuticals, TOT BIOPHARM and SAPA-China. It covers the whole process of early research and development, process development, mass production, industrialization and commercialization. We will bring together CEOs and top leaders of functional departments of local listed companies, as well as heads of R&D, production, quality, process and business of antibody enterprises at home and abroad through a platform of exchanges and cooperation for thousands of people.
8th Molecular Diagnostics Summit
The 8th Molecular Diagnostics Summit is co-organized by Enmore and KingMed Diagnostics. This time we focus on “molecular diagnostics market structure and corporate strategy”, “multi-platform detection technology for clinical diagnosis” and “to create competitive molecular diagnostic products”. Authoritative experts in precision medicine and outstanding enterprises such as Jiangsu Center for Clinical Laboratories, Shanghai Center for Clinical Laboratory, Berry Genomics, Geneseeq, and KingMed Diagnostics Group will participate in this summit. An invited-only CEO meeting will happen during the summit, organized by Clinical Laboratories leaders.
6th Immunotherapy Industry Summit
The 6th Immunotherapy Industry Summit aims to provide businesses with the industrialization of cellular immunotherapy in the next two years. The forum is jointly developed by experts and scholars in the field of cellular immunotherapy study, quality control leaders of first-tier companies, and CEOs of domestic and foreign companies with extensive industrialization experience! Companies and institutions involved include Fosun Kite Biotechnology Co., Ltd, JW Therapeutics, Cellular Biomedicine Group, PersonGene, Tongji Hospital, etc.
3rd 17TALK Healthcare Investment & Financing Leadership Forum
The 3rd 17TALK Healthcare Investment & Financing Leadership Forum is co-hosted by Enmore Healthcare and Everbright Medical & Healthcare Fund. The forum features healthcare investment trends and corporate listing, inviting local and international top investors to participate in the discussions. Special financing roadshows will be held to provide a financing platform for enterprises.
Who will attend EBC?
EBC 2019 attracted 2,208 attendees, and EBC 2020 is expected to exceed 3,000 attendees. The participating groups include entrepreneurs, scientists, clinicians, investors and suppliers, mostly CEOs and heads of R&D, production, quality, process and commercialization.
Part of EBC 2019 attendees
Antibody Drugs |
BIO-THERA |
Immunotherapy |
Gracell |
Antibody Drugs |
BeiGene |
Immunotherapy |
Lion TCR |
Antibody Drugs |
JOINN Laboratories (Beijing) |
Immunotherapy |
HRYZ BIO TECH CO. |
Antibody Drugs |
Boehringer-Ingelheim |
Immunotherapy |
GENE |
Antibody Drugs |
KANGHONG PHARMACEUTICAL |
Immunotherapy |
CARsgen Therapeutics |
Antibody Drugs |
TOT BIOPHARM |
Immunotherapy |
Nanjing Legend Pharmaceutical & Chemical Co., Ltd |
Antibody Drugs |
HARBOUR |
Immunotherapy |
Genscript |
Antibody Drugs |
Hutchison MediPharma |
Immunotherapy |
IASO BIO |
Antibody Drugs |
HENGRUI MEDICINE |
Immunotherapy |
HRAIN BIOTECHNOLOGY |
Antibody Drugs |
NCPC |
Immunotherapy |
Innovative Cellular Therapeutics Co.,Ltd. |
Antibody Drugs |
CR PHARMA COMM |
Immunotherapy |
Shanghai Cell Therapy Group Co.LTD |
Antibody Drugs |
Pfizer |
Immunotherapy |
JW Therapeutics |
Antibody Drugs |
CStone Pharmaceuticals |
Immunotherapy |
SHANGHAI UNICAR-THERAPY BIOMED-PHAMACEUTICAL TECHNOLOGY CO., LTD |
Antibody Drugs |
Genor Biopharma Co. Ltd. |
Immunotherapy |
Cellular Biomedicine Group |
Antibody Drugs |
Alphamab Co. Ltd |
Immunotherapy |
Eureka Therapeutics, Inc |
Antibody Drugs |
Elpiscience |
Immunotherapy |
Vcanbio |
Antibody Drugs |
Livzon International Limited |
Molecular Diagnostics |
Eppendorf |
Antibody Drugs |
Lunan Pharmaceutical Group |
Molecular Diagnostics |
ACON Laboratories |
Antibody Drugs |
Transcenta |
Molecular Diagnostics |
Genetron Health |
Antibody Drugs |
Mabtech Limited |
Molecular Diagnostics |
Leadmanbio |
Antibody Drugs |
GenScript Biotech Corporation |
Molecular Diagnostics |
DIAN DIAGNOSTICS GROUP CO LTD |
Antibody Drugs |
Qilu Pharmaceutical |
Molecular Diagnostics |
Berryoncology |
Antibody Drugs |
Johnson&Johnson |
Molecular Diagnostics |
Guangzhou KingMed Diagnostics Group Co., Ltd. |
Antibody Drugs |
Humanwell Healthcare |
Molecular Diagnostics |
Sansure Biotech Inc. |
Antibody Drugs |
RemeGen |
Molecular Diagnostics |
BGI |
Antibody Drugs |
ChemPartner |
Molecular Diagnostics |
Getein Biotech, Inc. |
Antibody Drugs |
3SBIO INC. |
Molecular Diagnostics |
Singlera Genomics |
Antibody Drugs |
Luye Pharma Group |
Molecular Diagnostics |
Luminex Corporation |
Antibody Drugs |
EpimAb Biotherapeutics |
Molecular Diagnostics |
Roche diagnostics (shanghai) limited |
Antibody Drugs |
Henlius |
Molecular Diagnostics |
Geneseeq Technology Inc. |
Antibody Drugs |
JMT-BIO |
Molecular Diagnostics |
PerkinElmer |
Antibody Drugs |
Shanghai Junshi Biosciences Co., Ltd. |
Molecular Diagnostics |
Hitachi |
Antibody Drugs |
Etana Biotechnologies Hong Kong Limited |
Molecular Diagnostics |
Amoy Diagnostics |
Antibody Drugs |
Roche |
Molecular Diagnostics |
Shanghai Kehua Bio-Engineering Co., Ltd. |
Antibody Drugs |
Shanghai Miracogen Inc. |
Molecular Diagnostics |
3dmedcare |
Antibody Drugs |
NewBio Therapeutics, Inc. |
Molecular Diagnostics |
Liferiver Bio–Tech |
Antibody Drugs |
Wuxi AppTec |
Molecular Diagnostics |
HaploX |
Antibody Drugs |
Klus Pharma Inc. |
Molecular Diagnostics |
Shenzhen New Industries Biomedical Engineering Co., Ltd. |
Antibody Drugs |
Suzhou Yabao Pharmaceutical R&D Co., Ltd. |
Molecular Diagnostics |
Wuhan YZY Medical Science&Technology Co.,Ltd |
Antibody Drugs |
Tasly Group |
Molecular Diagnostics |
simceredx |
Antibody Drugs |
Simcere Pharmaceutical Group |
Molecular Diagnostics |
Abbottmama |
Antibody Drugs |
Innovent |
Molecular Diagnostics |
Autobio |
Antibody Drugs |
YST |
Molecular Diagnostics |
Vcanbio |
Antibody Drugs |
WuXi Biologics |
Investment |
Northern Light Venture Capital |
Antibody Drugs |
Yichang Humanwell Pharmaceutical Co., Ltd |
Investment |
DeCheng Capital |
Antibody Drugs |
Zai Lab |
Investment |
GTJA INVESTMENT GROUP |
Antibody Drugs |
HISUN |
Investment |
GUOTAI JUNAN Securities |
Antibody Drugs |
Zhejiang Huahai Pharmaceutical Co., Ltd. |
Investment |
China SDIC GaoXin Industrial Investment Corp., Ltd |
Antibody Drugs |
Teruisi |
Investment |
China Resources (Holdings) Co., Ltd. |
Antibody Drugs |
CTTQ |
Investment |
Jemincare |
Antibody Drugs |
Akeso Biopharma |
Investment |
Legend Capital |
Immunotherapy |
IQVIA |
Investment |
Warburg Pincus |
Immunotherapy |
PersonGene |
Investment |
PING AN Ventures |
Immunotherapy |
BoyaLife |
Investment |
PWC |
Immunotherapy |
Fosun Kite Biotechnology Co., Ltd |
Investment |
SBCVC |
Immunotherapy |
Fosun Pharma |
Investment |
Oriza Holdings |
Conference Agenda of EBC 2020
Registration at EBC
Online registration:https://ienmore.com/enmoreweb/pc/index.html?language=1&activityId=1267
Consultation: healthcare@enmore.com
Like this:
Like Loading...